Insulin prices propel higher spending among diabetics

Data: Health Care Cost Institute; Chart: Naema Ahmed/Axios

The amount that people with Type 1 diabetes spent on insulin, before subtracting rebates and discounts, doubled from 2012 to 2016 while daily insulin use mostly stayed flat, according to a report from the Health Care Cost Institute, which analyzed health insurance claims from that time span.

The big picture: There are some limitations with the report's data. Regardless, insulin prices and out-of-pocket costs have enraged diabetic patients and parents, who have been at the forefront of the drug pricing debate by explaining how difficult it is to obtain the life-or-death medication.

Expert Voices

Global nutrition has improved, but targeted investments still needed

India, Bihar, Bodhgaya, A family eating vegetarian street food in Bodh.
A family eating vegetarian street food in Bodh, India. Photo: Eye Ubiquitous/UIG via Getty Images

Progress in reducing malnutrition has been slow and uneven, according to the newly released 2018 Global Nutrition Report. Although donors exceeded the $19.6 billion commitment they made in 2013, disbursing $21.8 billion two years ahead of schedule, the report also found that official development assistance is still too low.

The big picture: Malnutrition imposes high socioeconomic costs, the majority of which are borne by children, young adults, and women. While the quality of data on both problems and solutions has improved, more investment is needed in programs specific to nutrition, especially in the most challenged countries.

More stories loading.